SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-035661
Filing Date
2004-03-05
Accepted
2004-03-05 17:22:29
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 943832
3 CONSENT OF ERNST & YOUNG LLP INDEPENDENT PUBLIC ACCOUNTANTS dex231.htm EX-23.1 1950
4 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 8725
5 CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 8731
6 CERTIFICATION OF THE CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex321.htm EX-32.1 3754
7 CERTIFICATION OF THE CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex322.htm EX-32.2 3686
8 RISK FACTORS dex991.htm EX-99.1 130236
  Complete submission text file 0001193125-04-035661.txt   1103438
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-10824 | Film No.: 04652972
SIC: 2835 In Vitro & In Vivo Diagnostic Substances